German guideline for diagnosis and treatment of multiple sclerosis - a survey focusing neurologists in daily practise.
Journal
Multiple sclerosis and related disorders
ISSN: 2211-0356
Titre abrégé: Mult Scler Relat Disord
Pays: Netherlands
ID NLM: 101580247
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
05
04
2022
accepted:
21
04
2022
pubmed:
2
5
2022
medline:
29
6
2022
entrez:
1
5
2022
Statut:
ppublish
Résumé
We performed a web-based survey among German-speaking neurologists to evaluate the acceptance of the 2021 German guideline in the diagnosis and treatment of multiple sclerosis. Based on 327 replies in total, the current survey largely reproduced the findings of an earlier, smaller survey on the prefinal consultation version of the guideline and confirmed high acceptance rates. Half of the participants were practising neurologists. Neurologists from MS centers with more than 500 patients per year (n=26) were more critical of the guideline. They reiterated some of the criticisms of the previous feedback, and, in particular, felt that safety aspects are overemphasized in the guideline, thereby superseding early aggressive therapy.
Identifiants
pubmed: 35490449
pii: S2211-0348(22)00340-6
doi: 10.1016/j.msard.2022.103828
pii:
doi:
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
103828Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.